Showing results (241-250 of 276) with videos related to

Sort By:
Pageof 28
Journal of the National Cancer Institute|June 25, 2014
ABCA transporter gene expression and poor outcome in epithelial ovarian cancerEllen L Hedditch, Bo Gao, Amanda J Russell, et al.
NPJ Genomic Medicine|March 5, 2024
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual diseaseDhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
The Journal of Pathology|December 13, 2021
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomasKarolin Heinze, Tayyebeh M Nazeran, Sandra Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2013
Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcomeKristin L White, Robert A Vierkant, Zachary C Fogarty, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 18, 2014
Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancerMatthew S Block, Bridget Charbonneau, Robert A Vierkant, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2016
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer SurvivalLara E Sucheston-Campbell, Rikki Cannioto, Alyssa I Clay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association ConsortiumSharon E Johnatty, Jonathan P Tyrer, Siddhartha Kar, et al.
Cancer Immunology Research|April 26, 2014
Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeBridget Charbonneau, Kirsten B Moysich, Kimberly R Kalli, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2021
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinomaEun Young Kang, Joshua Millstein, Gordana Popovic, et al.
Pageof 28